Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol Fumarate versus Other Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis

In patients with chronic obstructive pulmonary disease (COPD) who experience further exacerbations or symptoms, despite being prescribed dual long-acting muscarinic antagonist (LAMA)/long-acting β(2)-agonist (LABA) or inhaled corticosteroid (ICS)/LABA therapies, triple ICS/LAMA/LABA therapy is recom...

Descripción completa

Detalles Bibliográficos
Autores principales: Bourdin, Arnaud, Molinari, Nicolas, Ferguson, Gary T., Singh, Barinder, Siddiqui, Mohd Kashif, Holmgren, Ulf, Ouwens, Mario, Jenkins, Martin, De Nigris, Enrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189959/
https://www.ncbi.nlm.nih.gov/pubmed/33929661
http://dx.doi.org/10.1007/s12325-021-01703-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189959/
https://www.ncbi.nlm.nih.gov/pubmed/33929661
http://dx.doi.org/10.1007/s12325-021-01703-z

Ejemplares similares